Sex differences in type 2 diabetes: focus on disease course and outcomes

References

• Danaei G Finucane MM Lu Y National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2(middle dot)7 million participants Lancet 2011 378 9785 31 40 21705069
   PubMed Web of Science ®Google Scholar
• Agardh EE Ahlbom A Andersson T Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged Swedish women Diabetes Care 2003 26 3 719 724 12610028
   PubMed Web of Science ®Google Scholar
• Misra R Lager J Ethnic and gender differences in psychosocial factors, glycemic control, and quality of life among adult type 2 diabetic patients J Diabetes Complications 2009 23 1 54 64 18413181
   PubMed Web of Science ®Google Scholar
• Shalev V Chodick G Heymann AD Kokia E Gender differences in healthcare utilization and medical indicators among patients with diabetes Public Health 2005 119 1 45 49 15560901
   PubMed Web of Science ®Google Scholar
• Tang YH Pang SM Chan MF Yeung GS Yeung VT Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitus J Adv Nurs 2008 62 1 74 83 18352966
   PubMed Web of Science ®Google Scholar
• Chiu CJ Wray LA Gender differences in functional limitations in adults living with type 2 diabetes: biobehavioral and psychosocial mediators Ann Behav Med 2011 41 1 71 82 20827519
   PubMed Web of Science ®Google Scholar
• Nilsson PM Theobald H Journath G Fritz T Gender differences in risk factor control and treatment profile in diabetes: a study in 229 swedish primary health care centres Scand J Prim Health Care 2004 22 1 27 31 15119517
   PubMed Web of Science ®Google Scholar
• Wexler DJ Grant RW Meigs JB Nathan DM Cagliero E Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes Diabetes Care 2005 28 3 514 520 15735180
   PubMed Web of Science ®Google Scholar
• Roche MM Wang PP Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late Diabetes Care 2013 36 9 2582 2590 23564923
   PubMed Web of Science ®Google Scholar
• Gregg EW Gu Q Cheng YJ Narayan KM Cowie CC Mortality trends in men and women with diabetes, 1971 to 2000 Ann Intern Med 2007 147 3 149 155 17576993
   PubMed Web of Science ®Google Scholar
• Legato MJ Gelzer A Goland R Gender-specific care of the patient with diabetes: review and recommendations Gend Med 2006 3 2 131 158 16860272
   PubMedGoogle Scholar
• Pilote L Dasgupta K Guru V A comprehensive view of sex-specific issues related to cardiovascular disease CMAJ 2007 176 6 S1 S44 17353516
   PubMed Web of Science ®Google Scholar
• Pasquali R Vicennati V Gambineri A Pagotto U Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity Int J Obes (Lond) 2008 32 12 1764 1779 18838976
   PubMed Web of Science ®Google Scholar
• Mattsson C Olsson T Estrogens and glucocorticoid hormones in adipose tissue metabolism Curr Med Chem 2007 14 27 2918 2924 18045137
   PubMed Web of Science ®Google Scholar
• Williams CM Lipid metabolism in women Proc Nutr Soc 2004 63 1 153 160 15070445
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 2000 21 6 697 738 11133069
   PubMed Web of Science ®Google Scholar
• Haarbo J Marslew U Gotfredsen A Christiansen C Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause Metabolism 1991 40 12 1323 1326 1961129
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V Lehmkuhl E Weickert MO Gender differences in the metabolic syndrome and their role for cardiovascular disease Clin Res Cardiol 2006 95 3 136 147 16598526
   PubMed Web of Science ®Google Scholar
• Geer EB Shen W Gender differences in insulin resistance, body composition, and energy balance Gend Med 2009 6 Suppl 1 60 75 19318219
   PubMed Web of Science ®Google Scholar
• Rebuffe-Scrive M Bronnegard M Nilsson A Eldh J Gustafsson JA Bjorntorp P Steroid hormone receptors in human adipose tissues J Clin Endocrinol Metab 1990 71 5 1215 1219 2229280
   PubMed Web of Science ®Google Scholar
• Krotkiewski M Bjorntorp P Sjostrom L Smith U Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution J Clin Invest 1983 72 3 1150 1162 6350364
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V Lehmkuhl E Mahmoodzadeh S Gender Aspects of the Role of the Metabolic Syndrome as a Risk Factor for Cardiovascular Disease Gend Med 2007 4 Suppl B S162 S177 18156101
   PubMedGoogle Scholar
• Dallongeville J Cottel D Arveiler D The association of metabolic disorders with the metabolic syndrome is different in men and women Ann Nutr Metab 2004 48 1 43 50 14646340
   PubMed Web of Science ®Google Scholar
• Szalat A Raz I Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women Diabetes Obes Metab 2008 10 12 1135 1156 18494812
   PubMed Web of Science ®Google Scholar
• Hanefeld M Koehler C Fuecker K Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study Diabetes Care 2003 26 3 868 874 12610051
   PubMed Web of Science ®Google Scholar
• Goldstein BJ Insulin resistance as the core defect in type 2 diabetes mellitus Am J Cardiol 2002 90 5 3G 10G
   Google Scholar
• Wild S Roglic G Green A Sicree R King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27 5 1047 1053 15111519
   PubMed Web of Science ®Google Scholar
• Gale EA Gillespie KM Diabetes and gender Diabetologia 2001 44 1 3 15 11206408
   PubMed Web of Science ®Google Scholar
• Sattar N Gender aspects in type 2 diabetes mellitus and cardiometabolic risk Best Pract Res Clin Endocrinol Metab 2013 27 4 501 507 24054927
   PubMed Web of Science ®Google Scholar
• Awa WL Fach E Krakow D Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database Eur J Endocrinol 2012 167 2 245 254 22645200
   PubMed Web of Science ®Google Scholar
• Lewitt MS Hilding A Brismar K Efendic S Ostenson CG Hall K IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women Eur J Endocrinol 2010 163 2 233 242 20508082
   PubMed Web of Science ®Google Scholar
• Lewitt MS Hilding A Ostenson CG Efendic S Brismar K Hall K Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men Diabetologia 2008 51 7 1135 1145 18496669
   PubMed Web of Science ®Google Scholar
• Pomerleau J McKeigue PM Chaturvedi N Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care 1999 22 3 430 433 10097924
   PubMed Web of Science ®Google Scholar
• Bjorntorp P Visceral obesity: a “civilization syndrome” Obes Res 1993 1 3 206 222 16350574
   PubMedGoogle Scholar
• Arnetz L The HPA Axis in Type 2 Diabetes – Some Aspects in Relation to Insulin Sensitivity, Beta-Cell Function and IGF-I/IGFBP-1 [doctoral thesis] Stockholm Department of Molecular Medicine and Surgery, Karolinska Institutet 2014
   Google Scholar
• Federman DD The biology of human sex differences N Engl J Med 2006 354 14 1507 1514 16598047
   PubMed Web of Science ®Google Scholar
• Mayes JS Watson GH Direct effects of sex steroid hormones on adipose tissues and obesity Obes Rev 2004 5 4 197 216 15458395
   PubMedGoogle Scholar
• Meyer MR Clegg DJ Prossnitz ER Barton M Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors Acta Physiol (Oxf) 2011 203 1 259 269 21281456
   PubMed Web of Science ®Google Scholar
• Seidell JC Bjorntorp P Sjostrom L Kvist H Sannerstedt R Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels Metabolism 1990 39 9 897 901 2202881
   PubMed Web of Science ®Google Scholar
• Tibblin G Adlerberth A Lindstedt G Bjorntorp P The pituitary-gonadal axis and health in elderly men: a study of men born in 1913 Diabetes 1996 45 11 1605 1609 8866567
   PubMed Web of Science ®Google Scholar
• Marin P Krotkiewski M Bjorntorp P Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues Eur J Med 1992 1 6 329 336 1341460
   PubMedGoogle Scholar
• Marin P Holmang S Gustafsson C Androgen treatment of abdominally obese men Obes Res 1993 1 4 245 251 16350577
   PubMedGoogle Scholar
• Ding EL Song Y Malik VS Liu S Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 2006 295 11 1288 1299 16537739
   PubMed Web of Science ®Google Scholar
• Polderman KH Gooren LJ Asscheman H Bakker A Heine RJ Induction of insulin resistance by androgens and estrogens J Clin Endocrinol Metab 1994 79 1 265 271 8027240
   PubMed Web of Science ®Google Scholar
• Bjorntorp P Neuroendocrine perturbations as a cause of insulin resistance Diabetes Metab Res Rev 1999 15 6 427 441 10634968
   PubMed Web of Science ®Google Scholar
• Nandi A Chen Z Patel R Poretsky L Polycystic Ovary Syndrome Endocrinol Metab Clin North Am 2014 43 1 123 147 24582095
   PubMed Web of Science ®Google Scholar
• Rincon J Holmang A Wahlstrom EO Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment Diabetes 1996 45 5 615 621 8621012
   PubMed Web of Science ®Google Scholar
• Korhonen S Hippelainen M Vanhala M Heinonen S Niskanen L The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study Fertil Steril 2003 79 6 1327 1334 12798879
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E Holbrook TL Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus JAMA 1992 268 23 3333 3337 1453525
   PubMed Web of Science ®Google Scholar
• Wake DJ Strand M Rask E Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity Clin Endocrinol (Oxf) 2007 66 3 440 446 17302881
   PubMed Web of Science ®Google Scholar
• Rajpathak SN Gunter MJ Wylie-Rosett J The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes Diabetes Metab Res Rev 2009 25 1 3 12 19145587
   PubMed Web of Science ®Google Scholar
• Gatford KL Egan AR Clarke IJ Owens PC Sexual dimorphism of the somatotrophic axis J Endocrinol 1998 157 3 373 389 9691971
   PubMed Web of Science ®Google Scholar
• Unden AL Elofsson S Knox S Lewitt MS Brismar K IGF-I in a normal population: Relation to psychosocial factors Clin Endocrinol (Oxf) 2002 57 6 793 803 12460330
   PubMed Web of Science ®Google Scholar
• Hilding A Brismar K Degerblad M Thoren M Hall K Altered relation between circulating levels of insulin-like growth factor- binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects J Clin Endocrinol Metab 1995 80 9 2646 2652 7545695
   PubMed Web of Science ®Google Scholar
• Baxter RC Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am J Physiol Endocrinol Metab 2000 278 6 E967 E976 10826997
   PubMed Web of Science ®Google Scholar
• Unden AL Elofsson S Brismar K Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: A population-based study Clin Endocrinol (Oxf) 2005 63 1 94 102 15963068
   PubMed Web of Science ®Google Scholar
• Cardim HJ Lopes CM Giannella-Neto D da Fonseca AM Pinotti JA The insulin-like growth factor-I system and hormone replacement therapy Fertil Steril 2001 75 2 282 287 11172828
   PubMed Web of Science ®Google Scholar
• Hu E Liang P Spiegelman BM AdipoQ is a novel adipose-specific gene dysregulated in obesity J Biol Chem 1996 271 18 10697 10703 8631877
   PubMed Web of Science ®Google Scholar
• Kadowaki T Yamauchi T Kubota N Hara K Ueki K Tobe K Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 2006 116 7 1784 1792 16823476
   PubMed Web of Science ®Google Scholar
• Halleux CM Takahashi M Delporte ML Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue Biochem Biophys Res Commun 2001 288 5 1102 1107 11700024
   PubMed Web of Science ®Google Scholar
• Maeda N Takahashi M Funahashi T PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 2001 50 9 2094 2099 11522676
   PubMed Web of Science ®Google Scholar
• Nishizawa H Shimomura I Kishida K Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 2002 51 9 2734 2741 12196466
   PubMed Web of Science ®Google Scholar
• Weyer C Funahashi T Tanaka S Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 2001 86 5 1930 1935 11344187
   PubMed Web of Science ®Google Scholar
• Cnop M Havel PJ Utzschneider KM Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 2003 46 4 459 469 12687327
   PubMed Web of Science ®Google Scholar
• Spranger J Kroke A Mohlig M Adiponectin and protection against type 2 diabetes mellitus Lancet 2003 361 9353 226 228 12547549
   PubMed Web of Science ®Google Scholar
• Dekker JM Funahashi T Nijpels G Prognostic value of adiponectin for cardiovascular disease and mortality J Clin Endocrinol Metab 2008 93 4 1489 1496 18211973
   PubMed Web of Science ®Google Scholar
• Unger RH The physiology of cellular liporegulation Annu Rev Physiol 2003 65 333 347 12471167
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E Sex differences in coronary heart disease: Why are women so superior? The 1995 Ancel Keys Lecture Circulation 1997 95 1 252 264 8994444
   PubMed Web of Science ®Google Scholar
• Thomas T Burguera B Melton LJ3rd Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women Metabolism 2000 49 10 1278 1284 11079816
   PubMed Web of Science ®Google Scholar
• Soderberg S Stegmayr B Stenlund H Leptin, but not adiponectin, predicts stroke in males J Intern Med 2004 256 2 128 136 15257725
   PubMed Web of Science ®Google Scholar
• Wallace AM McMahon AD Packard CJ Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS) Circulation 2001 104 25 3052 3056 11748099
   PubMed Web of Science ®Google Scholar
• Piemonti L Calori G Mercalli A Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality Diabetes Care 2003 26 10 2883 2889 14514596
   PubMed Web of Science ®Google Scholar
• Washington EL Shen JJ Gender discrepancies in the level of disease progression in hospitalized patients with diabetes Manag Care Interface 2006 19 10 21 25 17117595
   PubMedGoogle Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group Gerstein HC Miller ME Effects of Intensive Glucose Lowering in Type 2 Diabetes N Engl J Med 2008 358 24 2545 2559 18539917
   PubMed Web of Science ®Google Scholar
• ADVANCE Collaborative Group Patel A MacMahon S Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008 358 24 2560 2572 18539916
   PubMed Web of Science ®Google Scholar
• No authors listed Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet S1998 352 9131 854 865 9742977
   PubMed Web of Science ®Google Scholar
• Viberti G Kahn SE Greene DA A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes Diabetes Care 2002 25 10 1737 1743 12351470
   PubMed Web of Science ®Google Scholar
• McGill JB Vlajnic A Knutsen PG Recklein C Rimler M Fisher SJ Effect of gender on treatment outcomes in type 2 diabetes mellitus Diabetes Res Clin Pract 2013 102 3 167 174 24183259
   PubMed Web of Science ®Google Scholar
• Knowler WC Barrett-Connor E Fowler SE Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 2002 346 6 393 403 11832527
   PubMed Web of Science ®Google Scholar
• Perreault L Ma Y Dagogo-Jack S Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program Diabetes Care 2008 31 7 1416 1421 18356403
   PubMed Web of Science ®Google Scholar
• Tuthill A McKenna MJ O’Shea D McKenna TJ Weight changes in type 2 diabetes and the impact of gender Diabetes Obes Metab 2008 10 9 726 732 17941869
   PubMed Web of Science ®Google Scholar
• Hu FB Stampfer MJ Solomon C Physical activity and risk for cardiovascular events in diabetic women Ann Intern Med 2001 134 2 96 105 11177312
   PubMed Web of Science ®Google Scholar
• Loprinzi PD Pariser G Physical activity intensity and biological markers among adults with diabetes: considerations by age and gender J Diabetes Complications 2013 27 2 134 140 23068885
   PubMed Web of Science ®Google Scholar
• Penno G Solini A Bonora E Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study J Intern Med 2013 274 2 176 191 23565931
   PubMed Web of Science ®Google Scholar
• Kramer HU Ruter G Schottker B Gender differences in healthcare utilization of patients with diabetes Am J Manag Care 2012 18 7 362 369 22823530
   PubMed Web of Science ®Google Scholar
• Kramer HU Raum E Ruter G Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study Cardiovasc Diabetol 2012 11 88 22838970
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A Kamyar MR Gerhat D Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus Gend Med 2010 7 6 571 583 21195357
   PubMedGoogle Scholar
• Karim A Slater M Bradford D Oral antidiabetic drugs: bioavailability assessment of fixed-dose combination tablets of pioglitazone and metformin. Effect of body weight, gender, and race on systemic exposures of each drug J Clin Pharmacol 2007 47 1 37 47 17192500
   PubMed Web of Science ®Google Scholar
• Lyons MR Peterson LR McGill JB Impact of sex on the heart’s metabolic and functional responses to diabetic therapies Am J Physiol Heart Circ Physiol 2013 305 11 H1584 H1591 24043256
   PubMed Web of Science ®Google Scholar
• Walker EA Molitch M Kramer MK Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program Diabetes Care 2006 29 9 1997 2002 16936143
   PubMed Web of Science ®Google Scholar
• Biradar V Moran JL Peake SL Peter JV Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit Crit Care Resusc 2010 12 3 191 195 21261578
   PubMed Web of Science ®Google Scholar
• Pongwecharak J Tengmeesri N Malanusorn N Panthong M Pawangkapin N Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome Pharm World Sci 2009 31 4 481 486 19462255
   PubMed Web of Science ®Google Scholar
• Benz V Kintscher U Foryst-Ludwig A Sex-specific differences in Type 2 Diabetes Mellitus and dyslipidemia therapy: PPAR agonists Handb Exp Pharmacol 2012 214 387 410 23027460
   PubMedGoogle Scholar
• Dorkhan M Magnusson M Frid A Grubb A Groop L Jovinge S Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes J Intern Med 2006 260 2 125 133 16882276
   PubMed Web of Science ®Google Scholar
• Akazawa S Sun F Ito M Kawasaki E Eguchi K Efficacy of troglitazone on body fat distribution in type 2 diabetes Diabetes Care 2000 23 8 1067 1071 10937499
   PubMed Web of Science ®Google Scholar
• Flory JH Small DS Cassano PA Brillon DJ Mushlin AI Hennessy S Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin J Comp Eff Res 2014 3 1 29 39 24345255
   PubMed Web of Science ®Google Scholar
• Esteghamati A Noshad S Rabizadeh S Ghavami M Zandieh A Nakhjavani M Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial Regul Pept 2013 182 1 6 23328000
   PubMedGoogle Scholar
• Vlckova V Cornelius V Kasliwal R Wilton L Shakir S Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study J Eval Clin Pract 2010 16 6 1124 1128 21176002
   PubMed Web of Science ®Google Scholar
• Arnetz L Dorkhan M Alvarsson M Brismar K Ekberg NR Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes Acta Diabetologica 2014 51 2 185 192 23389468
   PubMed Web of Science ®Google Scholar
• Wheeler S Moore K Forsberg CW Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy Diabetologia Epub 6 25 2013
   Web of Science ®Google Scholar
• Pencek R Blickensderfer A Li Y Brunell SC Anderson PW Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index Postgrad Med 2012 124 4 21 32 22913891
   PubMed Web of Science ®Google Scholar
• Buysschaert M Preumont V Oriot PR One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice Diabetes Metab 2010 36 5 381 388 20598606
   PubMed Web of Science ®Google Scholar
• Damholt B Golor G Wierich W Pedersen P Ekblom M Zdravkovic M An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide J Clin Pharmacol 2006 46 6 635 641 16707410
   PubMed Web of Science ®Google Scholar
• Anichini R Cosimi S Di Carlo A Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience Diabetes Metab Syndr Obes 2013 6 123 129 23630427
   PubMedGoogle Scholar
• He YL Clinical pharmacokinetics and pharmacodynamics of vildagliptin Clin Pharmacokinet 2012 51 3 147 162 22339447
   PubMed Web of Science ®Google Scholar
• Deacon CF Holst JJ Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes Adv Ther 2009 26 5 488 499 19444391
   PubMed Web of Science ®Google Scholar
• Kajiwara A Saruwatari J Sakata M Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture Drug Saf 2013 36 10 981 987 23743694
   PubMed Web of Science ®Google Scholar
• Krepinsky J Ingram AJ Clase CM Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease Am J Kidney Dis 2000 35 3 500 505 10692277
   PubMed Web of Science ®Google Scholar
• Marbury T Huang WC Strange P Lebovitz H Repaglinide versus glyburide: a one-year comparison trial Diabetes Res Clin Pract 1999 43 3 155 166 10369424
   PubMed Web of Science ®Google Scholar
• Kasichayanula S Liu X Lacreta F Griffen SC Boulton DW Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2 Clin Pharmacokinet 2014 53 1 17 27 24105299
   PubMed Web of Science ®Google Scholar
• Amiel SA Maran A Powrie JK Umpleby AM Macdonald IA Gender differences in counterregulation to hypoglycaemia Diabetologia 1993 36 5 460 464 8314452
   PubMed Web of Science ®Google Scholar
• Diamond MP Jones T Caprio S Gender influences counterregulatory hormone responses to hypoglycemia Metabolism 1993 42 12 1568 1572 8246771
   PubMed Web of Science ®Google Scholar
• Korner A Wabitsch M Seidel B Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight Biochem Biophys Res Commun 2005 337 2 540 550 16202386
   PubMed Web of Science ®Google Scholar
• Wandell PE Gafvels C Patients with type 2 diabetes aged 35–64 years at four primary health care centres in Stockholm County, Sweden. Prevalence and complications in relation to gender and socio-economic status Diabetes Res Clin Pract 2004 63 3 195 203 14757291
   PubMed Web of Science ®Google Scholar
• Kajiwara A Miyagawa H Saruwatari J Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: A clinic-based retrospective longitudinal study Diabetes Res Clin Pract 2014 103 3 e7 e10 24503044
   PubMed Web of Science ®Google Scholar
• Afzal N Zaman S Asghar A Negative Association of Serum IL-6 and IL-17 with Type-II Diabetes Retinopathy Iran J Immunol 2014 11 1 40 48 24632587
   PubMed Web of Science ®Google Scholar
• Kostev K Rathmann W Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis Diabetologia 2013 56 1 109 111 23052061
   PubMed Web of Science ®Google Scholar
• Liu JH Tung TH Tsai ST A community-based epidemiologic study of gender differences in the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type 2 diabetic patients in Kinmen, Taiwan Ophthalmologica 2006 220 4 252 258 16785757
   PubMed Web of Science ®Google Scholar
• Aaberg ML Burch DM Hud ZR Zacharias MP Gender differences in the onset of diabetic neuropathy J Diabetes Complications 2008 22 2 83 87 18280437
   PubMed Web of Science ®Google Scholar
• Nakhjavani M Morteza A Jenab Y Gender difference in albuminuria and ischemic heart disease in type 2 diabetes Clin Med Res 2012 10 2 51 56 22031479
   PubMedGoogle Scholar
• Dickman R Wainstein J Glezerman M Niv Y Boaz M Gender aspects suggestive of gastroparesis in patients with diabetes mellitus: a cross-sectional survey BMC Gastroenterol 2014 14 1 34 24552174
   PubMed Web of Science ®Google Scholar
• Peek ME Gender differences in diabetes-related lower extremity amputations Clin Orthop Relat Res 2011 469 7 1951 1955 21161738
   PubMed Web of Science ®Google Scholar
• Bruun C Siersma V Guassora AD Holstein P de Fine Olivarius N Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity Diabet Med 2013 30 8 964 972 23617411
   PubMed Web of Science ®Google Scholar
• Janghorbani M Hedley AJ Jones RB Zhianpour M Gilmour WH Gender differential in all-cause and cardiovascular disease mortality Int J Epidemiol 1993 22 6 1056 1063 8144286
   PubMed Web of Science ®Google Scholar
• Carr MC The emergence of the metabolic syndrome with menopause J Clin Endocrinol Metab 2003 88 6 2404 2411 12788835
   PubMed Web of Science ®Google Scholar
• Welty FK Women and cardiovascular risk American J Cardiol 2001 88 7b 48J 52J
   Web of Science ®Google Scholar
• Kalyani RR Lazo M Ouyang P Gender Differences in Diabetes and Risk of Incident Coronary Artery Disease in Healthy Young and Middle-Aged Adults Diabetes Care 2014 37 3 830 838 24178997
   PubMed Web of Science ®Google Scholar
• Lundberg V Stegmayr B Asplund K Eliasson M Huhtasaari F Diabetes as a risk factor for myocardial infarction: population and gender perspectives J Intern Med 1997 241 6 485 492 10497624
   PubMed Web of Science ®Google Scholar
• Manson JE Colditz GA Stampfer MJ A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women Arch Intern Med 1991 151 6 1141 1147 2043016
   PubMedGoogle Scholar
• Wu YT Chien CL Wang SY Yang WS Wu YW Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus J Womens Health (Larchmt) 2013 22 5 439 444 23600438
   PubMed Web of Science ®Google Scholar
• Hung MJ Hsu KH Hu WS Chang NC Hung MY C-reactive protein for predicting prognosis and its gender-specific associations with diabetes mellitus and hypertension in the development of coronary artery spasm PloS One 2013 8 10 e77655 24204905
   PubMed Web of Science ®Google Scholar
• Martinez-Selles M Doughty RN Poppe K Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis Eur J Heart Fail 2012 14 5 473 479 22402958
   PubMed Web of Science ®Google Scholar
• Legato MJ Gender and its Impact of Risk Factors for Cardiovascular Disease Principles of Gender-Specific Medicine San Diego, CA Elsevier Academic Press 2004 1
   Google Scholar
• Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications J Hypertens 1993 11 3 309 317 8387089
   PubMed Web of Science ®Google Scholar
• Elveback LR Connolly DC Melton LJ3rd Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982 Mayo Clin Proc 1986 61 11 896 900 3762228
   PubMed Web of Science ®Google Scholar
• Walden CE Knopp RH Wahl PW Beach KW Strandness EJr Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations N Engl J Med 1984 311 15 953 959 6472421
   PubMed Web of Science ®Google Scholar
• Mosca L Manson JE Sutherland SE Langer RD Manolio T Barrett-Connor E Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group Circulation 1997 96 7 2468 2482 9337227
   PubMed Web of Science ®Google Scholar
• Schroeder EB Bayliss EA Daugherty SL Steiner JF Gender differences in cardiovascular risk factors in incident diabetes Women’s Health Issues 2014 24 1 e61 e68 24439948
   PubMed Web of Science ®Google Scholar
• Hu G Jousilahti P Qiao Q Katoh S Tuomilehto J Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction Diabetologia 2005 48 5 856 861 15827741
   PubMed Web of Science ®Google Scholar
• Hu G DECODE Study Group Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes Diabetologia 2003 46 5 608 617 12750769
   PubMed Web of Science ®Google Scholar
• Kanaya AM Grady D Barrett-Connor E Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis Arch Intern Med 2002 162 15 1737 1745 12153377
   PubMedGoogle Scholar
• Goldschmid MG Barrett-Connor E Edelstein SL Wingard DL Cohn BA Herman WH Dyslipidemia and ischemic heart disease mortality among men and women with diabetes Circulation 1994 89 3 991 997 8124839
   PubMed Web of Science ®Google Scholar
• Lee C Joseph L Colosimo A Dasgupta K Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis Diabetes Metab 2012 38 5 420 427 22682738
   PubMed Web of Science ®Google Scholar
• Shekelle PG Rich MW Morton SC Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials J Am Coll Cardiol 2003 41 9 1529 1538 12742294
   PubMed Web of Science ®Google Scholar
• Walsh JM Pignone M Drug treatment of hyperlipidemia in women JAMA 2004 291 18 2243 2252 15138247
   PubMed Web of Science ®Google Scholar
• Shigematsu E Yamakawa T Taguri M Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes J Atheroscler Thromb 2012 19 9 846 853 22785138
   PubMed Web of Science ®Google Scholar
• Howard BV Cowan LD Go O Welty TK Robbins DC Lee ET Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study Diabetes Care 1998 21 8 1258 1265 9702430
   PubMed Web of Science ®Google Scholar
• Franconi F Campesi I Occhioni S Tonolo G Sex-gender differences in diabetes vascular complications and treatment Endocr Metab Immune Disord Drug Targets 2012 12 2 179 196 22236023
   PubMedGoogle Scholar
• Gilbert J Raboud J Zinman B Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting Diabetes Care 2004 27 4 990 994 15047662
   PubMed Web of Science ®Google Scholar
• Jacobs AK Johnston JM Haviland A Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry J Am Coll Cardiol 2002 39 10 1608 1614 12020487
   PubMed Web of Science ®Google Scholar
• Mehilli J Kastrati A Bollwein H Gender and restenosis after coronary artery stenting Eur Heart J 2003 24 16 1523 1530 12919777
   PubMed Web of Science ®Google Scholar
• Legato MJ Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy Am J Cardiol 2000 86 12A 15L 18L
   Web of Science ®Google Scholar
• Orchard TJ The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus Ann Med 1996 28 4 323 333 8862687
   PubMed Web of Science ®Google Scholar
• Steinberg HO Paradisi G Cronin J Type II diabetes abrogates sex differences in endothelial function in premenopausal women Circulation 2000 101 17 2040 2046 10790344
   PubMed Web of Science ®Google Scholar
• Chan P Pan WH Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients Diabet Med 1995 12 6 504 507 7648824
   PubMed Web of Science ®Google Scholar
• Mascarenhas-Melo F Marado D Palavra F Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women Cardiovasc Diabetol 2013 12 61 23570342
   PubMed Web of Science ®Google Scholar
• Nakhjavani M Morteza A Meysamie A Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter? Cell Stress Chaperones 2011 16 2 195 201 20872261
   PubMed Web of Science ®Google Scholar
• Schenck-Gustafsson K Diagnosis of cardiovascular disease in women Menopause Int 2007 13 1 19 22 17448263
   PubMedGoogle Scholar
• Zelenko Z Gallagher EJ Diabetes and Cancer Endocrinol Metab Clin North Am 2014 43 1 167 185 24582097
   PubMed Web of Science ®Google Scholar
• Vestergaard P Starup-Linde J Diabetes, cancer and treatment – a mini-review Curr Drug Saf 2013 8 5 292 295 24215309
   PubMedGoogle Scholar
• Kramer HU Muller H Stegmaier C Rothenbacher D Raum E Brenner H Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia Eur J Epidemiol 2012 27 5 341 347 22527209
   PubMed Web of Science ®Google Scholar
• Tseng CH Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan Diabetologia 2011 54 8 2009 2015 21544514
   PubMed Web of Science ®Google Scholar
• Chiou WK Hwang JS Hsu KH Lin JD Diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients Exp Diabetes Res 2012 2012 701643 22701471
   PubMedGoogle Scholar
• Sun GE Wells BJ Yip K Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus Diabetes Obes Metab 2014 16 3 276 283 24199848
   PubMed Web of Science ®Google Scholar
• Siddiqui MA Khan MF Carline TE Gender differences in living with diabetes mellitus Materia Sociomed 2013 25 2 140 142
   Google Scholar
• Anderson RJ Freedland KE Clouse RE Lustman PJ The prevalence of comorbid depression in adults with diabetes: a meta-analysis Diabetes Care 2001 24 6 1069 1078 11375373
   PubMed Web of Science ®Google Scholar
• Muller G Hartwig S Greiser KH Gender differences in the association of individual social class and neighbourhood unemployment rate with prevalent type 2 diabetes mellitus: a cross-sectional study from the DIAB-CORE consortium BMJ Open 2013 3 6 1 11
   Web of Science ®Google Scholar
• Eriksson AK Ekbom A Granath F Hilding A Efendic S Ostenson CG Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women Diabetic Med 2008 25 7 834 842 18513304
   PubMed Web of Science ®Google Scholar
• Eriksson AK van den Donk M Hilding A Ostenson CG Work stress, sense of coherence, and risk of type 2 diabetes in a prospective study of middle-aged Swedish men and women Diabetes Care 2013 36 9 2683 2689 23637356
   PubMed Web of Science ®Google Scholar
• Svenningsson I Bjorkelund C Marklund B Gedda B Anxiety and depression in obese and normal-weight individuals with diabetes type 2: a gender perspective Scand J Caring Sci 2012 26 2 349 354 22077658
   PubMed Web of Science ®Google Scholar
• Nau DP Aikens JE Pacholski AM Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus Gend Med 2007 4 3 205 213 18022588
   PubMedGoogle Scholar